Answer
It is a targeted tyrosine kinase inhibitor rather than conventional cytotoxic chemotherapy. It blocks VEGF receptors involved in tumour blood-vessel formation.
Sources for this answer
- FRUZAQLA 1 mg hard capsulesemc · SmPC Current selected SmPC · Version 3